Stockreport

Purple Biotech Reports Third Quarter 2024 Financial Results

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF Topline data from Phase 2 CM24 pancreatic cancer trial expected by the end of 2024 New CM24 biomarkers data presented during the third quarter of 2024 including two pre [Read more]